Literature DB >> 24196276

In trans T cell tolerance exacerbates experimental allergic encephalomyelitis by interfering with protective antibody responses.

Jason A Cascio1, Marie-Therese Khairallah1, Xiaoxiao Wan1, Weirong Chen1, Linda M Rowland1, Mermagya Dhakal1, Mindy M Miller1, Habib Zaghouani2.   

Abstract

F1 (SJL/J×C57BL/6) mice with MOG35-55-induced EAE recover from disease when treated with Ig-MOG carrying MOG35-55 peptide. However, Ig-PLP1, carrying PLP139-151, induced reduction of anti-MOG antibodies and exacerbated EAE. Herein, we show that Ig-PLP1 specifically reduces the frequency of B cells producing protective IgG2a/b anti-MOG antibodies. Surprisingly, these cells were marginal zone (MZ), rather than follicular (FO) or newly formed (NF), B cells and transfer of MZ B cells into sick mice nullified disease exacerbation by Ig-PLP1 in a complement dependent manner. These findings reveal a potential self-limiting regulatory mechanism involving auto-antibodies in MOG EAE.
© 2013.

Entities:  

Keywords:  Anti-MOG antibodies; Autoimmunity; B cells; EAE; T cell tolerance

Mesh:

Substances:

Year:  2013        PMID: 24196276      PMCID: PMC4762480          DOI: 10.1016/j.jneuroim.2013.09.022

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  36 in total

1.  T cell dynamics during induction of tolerance and suppression of experimental allergic encephalomyelitis.

Authors:  Rohit D Divekar; Cara L Haymaker; Jason A Cascio; Betul F Guloglu; Jason S Ellis; Danielle M Tartar; Christine M Hoeman; Craig L Franklin; Bernd H Zinselmeyer; Jennifer N Lynch; Mark J Miller; Habib Zaghouani
Journal:  J Immunol       Date:  2011-09-12       Impact factor: 5.422

2.  Late B cell depletion with a human anti-human CD20 IgG1κ monoclonal antibody halts the development of experimental autoimmune encephalomyelitis in marmosets.

Authors:  Yolanda S Kap; Nikki van Driel; Erwin Blezer; Paul W H I Parren; Wim K Bleeker; Jon D Laman; Jenny L Craigen; Bert A 't Hart
Journal:  J Immunol       Date:  2010-08-25       Impact factor: 5.422

3.  Antibody response in MOG(35-55) induced EAE.

Authors:  Patrice H Lalive; Nicolas Molnarfi; Mahdia Benkhoucha; Martin S Weber; Marie-Laure Santiago-Raber
Journal:  J Neuroimmunol       Date:  2011-10-10       Impact factor: 3.478

Review 4.  Autoantibodies in inflammatory demyelinating diseases of the central nervous system.

Authors:  Patrice H Lalive
Journal:  Swiss Med Wkly       Date:  2008-11-29       Impact factor: 2.193

5.  In trans T cell tolerance diminishes autoantibody responses and exacerbates experimental allergic encephalomyelitis.

Authors:  J Jeremiah Bell; Rohit D Divekar; Jason S Ellis; Jason A Cascio; Cara L Haymaker; Renu Jain; Danielle M Tartar; Christine M Hoeman; John C Hardaway; Habib Zaghouani
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

Review 6.  Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes.

Authors:  Andrea Cerutti; Montserrat Cols; Irene Puga
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

7.  Transient decomplementation of mice delays onset of experimental autoimmune encephalomyelitis and impairs MOG-specific T cell response and autoantibody production.

Authors:  Nóra Terényi; Nándor Nagy; Krisztián Papp; József Prechl; Imre Oláh; Anna Erdei
Journal:  Mol Immunol       Date:  2009-02-08       Impact factor: 4.407

8.  Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis.

Authors:  Til Menge; Patrice H Lalive; H Christian von Büdingen; Claude P Genain
Journal:  J Neuroinflammation       Date:  2011-11-17       Impact factor: 8.322

9.  Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.

Authors:  Bernadette Pöllinger; Gurumoorthy Krishnamoorthy; Kerstin Berer; Hans Lassmann; Michael R Bösl; Robert Dunn; Helena S Domingues; Andreas Holz; Florian C Kurschus; Hartmut Wekerle
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

10.  Extrafollicular B cell activation by marginal zone dendritic cells drives T cell-dependent antibody responses.

Authors:  Craig P Chappell; Kevin E Draves; Natalia V Giltiay; Edward A Clark
Journal:  J Exp Med       Date:  2012-09-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.